By 27 February 2020, the outbreak of coronavirus disease 2019 (COVID‐19) caused 82 623
confirmed cases and 2858 deaths globally, more than severe acute respiratory syndrome …

Importance The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an …

Objective To assess the efficacy and safety of hydroxychloroquine plus standard of care
compared with standard of care alone in adults with coronavirus disease 2019 (covid-19) …

Human coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus
(SARS-CoV) and 2019 novel coronavirus (2019-nCoV, also known as SARS-CoV-2), lead …

What started as a cluster of patients with a mysterious respiratory illness in Wuhan, China, in
December 2019, was later determined to be coronavirus disease 2019 (COVID-19). The …

On 10 January 2020, a new coronavirus causing a pneumonia outbreak in Wuhan City in
central China was denoted as 2019-nCoV by the World Health Organization (WHO). As of …

Background Hydroxychloroquine or chloroquine with or without azithromycin have been
widely promoted to treat coronavirus disease 2019 (COVID-19) following early in vitro …

Pathogenic coronaviruses are a major threat to global public health, as exemplified by
severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory …

Objective This study aims to evaluate the correlation between viral clearance and blood
biochemical index of 94 discharged patients with COVID-19 infection in Shenzhen Third …

Recently, a novel coronavirus initially designated 2019-nCoV but now termed SARS-CoV-2
has emerged and raised global concerns due to its virulence. SARS-CoV-2 is the etiological …